Factor V Leiden and contraception

Journal of Midwifery and Women's Health

Volumn 49, Issue 1, 2004, Pages 51-52

  Ament, Lynette ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Factor V Leiden; Hypercoagulability; Oral contraceptives; Venous thromboembolism

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; ESTROGEN; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CONTRACEPTION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETICS; HORMONAL CONTRACEPTION; HUMAN; HYPERCOAGULABILITY; IATROGENIC DISEASE; PATHOPHYSIOLOGY; THROMBOPHILIA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADULT; CONTRACEPTION; CONTRACEPTIVES, ORAL; FACTOR V; FEMALE; HUMANS; VENOUS THROMBOSIS;

EID: 0347657379     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2003.10.004     Document Type: Article

References (17)

1. Vincenzo S. Vincenzo A. Francesco M. The impact of the Factor V Leiden mutation on pregnancy Hum Reprod Update 6 2000 301-306
2. Middeldorp S. Meinardi J.R. Koopman M. van Pampus E. Hamulyak K. van der Meer J. et al. A prospective study of asymptomatic carriers of the Factor V Leiden mutation to determine the incidence of venous thromboembolism Ann Intern Med 135 2001 322-327
3. Zoller B. Svensson P.J. He X. Dahlback B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis prone families with inherited resistance to activated protein C J Clin Invest 94 1994 2521-2524
4. Dahlback B. Resistance to activated protein C, the Arg 506 to Gln mutation in the factor V gene, and venous thrombosis Thromb Haemost 73 1995 739-742
5. Livingston J.C. Barton J.R. Park V. Haddad B. Phillips O. Sibai B.M. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia Am J Obstet Gynecol 185 2001 153-157
6. Creinin M. Lisman R. Strickler R. Screening for factor V Leiden mutation before prescribing combination oral contraceptives Fertl Steril 72 1999 646-651
7. Ridker P.M. Miletich J.P. Hennekens C.H. Buring J.E. Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening J Am Med Assoc 277 1997 1305-1307
8. Quest Diagnotistics Laboratory Report, 2002
9. Lockwood C.J. Heritable coagulopathies in pregnancy Obstet Gynecol Surv 54 1999 754-765
10. Bonnar J. Green R. Norris L. Perinatal aspects of inherited thrombophilia Semin Thromb Hemost 25 1999 481-485
11. American College of Obstetrics and Gynecology. Thromboembolism in pregnancy 2000 19 ACOG Practice BulletinWashington (DC)
12. Ament L. Factor V Leiden: a review of the literature J Perinat Neonat Nurs 17 2003 190-195
13. Grody WW, Griffin JH, Taylor AK, Korf BR, Heit JA, the ACMG Factor V Leiden Working Group. American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing. Genetics in Medicine 2001;3:139-48. [cited September 20, 2003] Available from: http://www.geneticsinmedicine.org/
14. Jick H. Jick S.S. Gurewich V. Myers M.W. Vasiladis C. Risk of idiopathic death and non-fatal thromboembolism in women using oral contraceptives with different progestogen components Lancet 346 1995 1588-1593
15. Herrington D. Vittinghoff E. Howard T. Major D. Owen J. Reboussin D. et al. Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease Arterioscler Thromb Vasc Biol 22 2002 1012-1017
16. Speroff L. Darney P. A clinical guide for contraception, 3rd ed 2001 50 Lippincott Williams & WilkinsPhiladelphia (PA)
17. Bloomenthal D. von Dadelszen P. Liston R. Magee L. Tsang P. The effect of Factor V Leiden carriage on maternal and fetal health Can Med Assoc J 167 2002 48-54